Bone Marrow Transplantation without Myeloablation for Sickle Cell Disease
- 4 January 2001
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 344 (1) , 68
- https://doi.org/10.1056/nejm200101043440119
Abstract
Bone marrow transplantation can eliminate sickle cell disease and halt end-organ damage.1,2 However, the applicability of the procedure is limited because of the toxic effects associated with conventional bone marrow transplantation. Nonmyeloablative conditioning regimens can decrease or eliminate such toxic effects.3-5Keywords
This publication has 4 references indexed in Scilit:
- Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignanciesTransplantation and Cellular Therapy, 2000
- Bone marrow transplantation for hemoglobinopathiesCurrent Opinion in Hematology, 2000
- Nonmyeloablative stem cell transplantsCurrent Opinion in Hematology, 1999
- Reinventing bone marrow transplantation: reducing toxicity using nonmyeloablative, preparative regimens and induction of graft-versus-malignancyCurrent Opinion in Oncology, 1999